Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Qiagen Starts Marketing Own Diagnostic Agents In Japan

This article was originally published in PharmAsia News

Executive Summary

German diagnostics maker Qiagen started marketing three diagnostic agents and two samplers in Japan. The three diagnostics agents use proprietary Hybrid Capture for human papillomavirus, chlamydia and gonococci DNA tests; the company also launched samplers for HPV and other sexually transmitted diseases. Previously, Qiagen products were marketed through Tokyo-based Mitsubishi Chemical Medicine. Qiagen Japanese subsidiary last year obtained the marketing approval and it is now co-promoting HPV products with Mitsubishi. Qiagen Japan has less than 20 sales representatives and the company plans to increase that number as its own marketing operations takes off. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts